Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Obsessive-compulsive disorder (OCD) is a disabling, mostly chronic, psychiatric condition with significant social and economic impairments and is a major public health issue. However, numerous patients are resistant to currently available pharmacological and psychological interventions. Given that recent animal studies and magnetic resonance spectroscopy research points to glutamate dysfunction in OCD, we investigated the metabotropic glutamate receptor 5 (mGluR5) in patients with OCD and healthy controls. We determined mGluR5 distribution volume ratio (DVR) in the brain of ten patients with OCD and ten healthy controls by using [11C]ABP688 positron-emission tomography. As a clinical measure of OCD severity, the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was employed. We found no significant global difference in mGluR5 DVR between patients with OCD and healthy controls. We did, however, observe significant positive correlations between the Y-BOCS obsession sub-score and mGluR5 DVR in the cortico-striatal-thalamo-cortical brain circuit, including regions of the amygdala, anterior cingulate cortex, and medial orbitofrontal cortex (Spearman's ρ's⩾ = 0.68, p < 0.05). These results suggest that obsessions in particular might have an underlying glutamatergic pathology related to mGluR5. The research indicates that the development of metabotropic glutamate agents would be useful as a new treatment for OCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Neuroimaging and frontal–subcortical circuitry in obsessive–compulsive disorder
Saxena, S., Brody, A. L., Schwartz, J. M., & Baxter, L. R. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297870 · Cited by 831 · cited 2×
“On the basis of previous theories suggesting the involvement of the cortico-striatalthalamo-cortical brain circuit glutamate concentration in OCD (Saxena et al., 1998; Wu et al., 2012), we predicted changes in mGluR5 distribution volume ratio within regions of interest (ROIs) that are part of this…”
Toward a Neurodevelopmental Model of Obsessive–Compulsive Disorder
Rosenberg, D. R., & Keshavan, M. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00443-5 · Cited by 355 · cited 4×
“…have consistently been reported in those regions that we also determined to be significantly affected, such as the amygdala (Rosenberg and Keshavan, 1998), ACC (Szeszko et al., 2008) and orbitofrontal cortex (Rosenberg and Keshavan, 1998; Szeszko et al., 2008; van den Heuvel et al., 2009).”
InfluentialDeschwanden, A., Karolewicz, B., Feyissa, A. M., Treyer, V., Ametamey, S. M., Johayem, A., Burger, C., Auberson, Y. P., Sovago, J., Stockmeier, C. A., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.09111607 · Cited by 278
Self-citationThe role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder
Wu, K., Hanna, G. L., Rosenberg, D. R., & Arnold, P. D. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.007 · Cited by 264 · cited 3×
“…theories suggesting the involvement of the cortico-striatalthalamo-cortical brain circuit glutamate concentration in OCD (Saxena et al., 1998; Wu et al., 2012), we predicted changes in mGluR5 distribution volume ratio within regions of interest (ROIs) that are part of this brain circuit,…”
Yale-Brown Obsessive Compulsive Scale
Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., Heninger, G. R., & Charney, D. S. (2017) · PsycTESTS Dataset · doi:10.1037/t57982-000 · Cited by 179
Szeszko, P. R., Christian, C., MacMaster, F., Lencz, T., Mirza, Y., Taormina, S. P., Easter, P., Rose, M., Michalopoulou, G. A., & Rosenberg, D. R. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08010033 · Cited by 143 · cited 5×
“…with glutamatergic changes in key regions mediating such responses (i.e. the amygdala, ACC and orbitofrontal cortex (Rosenberg and Keshavan, 1998; Szeszko et al., 2008; van den Heuvel et al., 2009)), whereas compulsions might have a stronger motor component, potentially associated with changes…”
InfluentialGenetics of obsessive-compulsive disorder
Nestadt, G., Grados, M., & Samuels, J. F. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.11.001 · Cited by 105
Cited by
Howard, D. M., Adams, M. J., Shirali, M., Clarke, T.-K., Marioni, R. E., Davies, G., Coleman, J. R. I., Alloza, C., Shen, X., Barbu, M. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03819-3 · Cited by 612
Ade, K. K., Wan, Y., Hamann, H. C., O’Hare, J. K., Guo, W., Quian, A., Kumar, S., Bhagat, S., Rodriguiz, R. M., Wetsel, W. C., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.023 · Cited by 84
Hu, X., Du, M., Chen, L., Li, L., Zhou, M., Zhang, L., Liu, Q., Lu, L., Mreedha, K., Huang, X., et al. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.012 · Cited by 75
Dogra, S., & Conn, P. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108687 · Cited by 71
Esterlis, I., Holmes, S. E., Sharma, P., Krystal, J. H., & DeLorenzo, C. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.025 · Cited by 50
“matched controls were reported.(100) However, there was a positive correlation between mGluR5 and obsessive symptoms measured using Yale Brown Obsessive Compulsive Scale (Y-BOCS).”
Metadata
- Authors
- Akkus, F., Terbeck, S., Ametamey, S. M., Rufer, M., Treyer, V., Burger, C., Johayem, A., Mancilla, B. G., Sovago, J., Buck, A., & Hasler, G.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05-15
- Volume
- 17
- Issue
- 12
- Pages
- 1915-1922
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2072209865
- Cited by
- 54
- References
- 8
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. https://app.cochat.ai/papers/10.1017/s1461145714000716
- The paper
- Akkus, F., Terbeck, S., Ametamey, S. M., Rufer, M., Treyer, V., Burger, C., Johayem, A., Mancilla, B. G., Sovago, J., Buck, A., & Hasler, G. (2014). Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145714000716
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.